The bioactivities of sclareol: A mini review
- PMID: 36263135
- PMCID: PMC9574335
- DOI: 10.3389/fphar.2022.1014105
The bioactivities of sclareol: A mini review
Abstract
Sclareol, a diterpene alcohol isolated from the herbal and flavor plant clary sage (Salvia sclarea L.), is far-famed as the predominant ingredient in the refined oil of Salvia sclarea (L.). The empirical medicine of Salvia sclarea L. focused on various diseases, such as arthritis, oral inflammation, digestive system diseases, whereas the sclareol possessed more extensive and characteristic bioactivities, including anti-tumor, anti-inflammation and anti-pathogenic microbes, even anti-diabetes and hypertension. However, there is a deficiency of literature to integrate and illuminate the pharmacological attributes of sclareol based on well-documented investigations. Interestingly, sclareol has been recently considered as the potential candidate against COVID-19 and Parkinson's disease. Accordingly, the bioactive attributes of sclareol in cancer, inflammation, even pharmacochemistry and delivery systems are reviewed for comprehensively dissecting its potential application in medicine.
Keywords: bioactivities; cancer; delivery; inflammation; sclareol.
Copyright © 2022 Zhou, Xie, Tang, Peng and Peng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Afshari H., Nourbakhsh M., Salehi N., Mahboubi_Rabbani M., Zarghi A., Noori S. (2020). STAT3-mediated apoptotic-enhancing function of sclareol against breast cancer cells and cell sensitization to cyclophosphamide. Iran. J. Pharm. Res. 19 (1), 398–412. 10.22037/ijpr.2020.112587.13843 - DOI - PMC - PubMed
-
- Balinova-Tsvetkova A., Tsankova P. (1992). On the extraction of salvia sclarea L. Flavour Fragr. J. 7 (3), 151–154. 10.1002/ffj.2730070310 - DOI
-
- Borges G. S. M., Prazeres P., de Souza A. M., Yoshida M. I., Vilela J. M. C., Silva A., et al. (2021). Nanostructured lipid carriers as a novel tool to deliver sclareol: Physicochemical characterisation and evaluation in human cancer cell lines. Braz. J. Pharm. Sci. 57. 10.1590/s2175-97902020000418497 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
